Skip to main content
LLY
NYSE Life Sciences

Investigational Retatrutide Shows 23.7% Weight Loss; Eli Lilly's Q1 Earnings Report Imminent

Tom Rudovsky · Reported by Wiseek News
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$852.63
Mkt Cap
$804.239B
52W Low
$623.78
52W High
$1,133.95
52W Position info
37% above low
Off High info
25% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

LLY sits 37% above its 52-week low of $623.78.

Summary

Eli Lilly's investigational drug, Retatrutide, demonstrated highly promising efficacy with up to 23.7% mean weight loss in clinical trials, a significant development for its robust GLP-1 pipeline. This positive update comes as the company prepares to report its Q1 2026 earnings before market open today, with analysts expecting strong results, including $17.82 billion in revenue, driven by continued demand for its weight-loss medications. The strong Retatrutide data reinforces Eli Lilly's leadership in the lucrative obesity market and de-risks a key future growth driver. Traders will closely monitor the actual Q1 results for any surprises and further details on the seven Phase 3 readouts for Retatrutide expected by year-end.

At the time of this announcement, LLY was trading at $852.63 on NYSE in the Life Sciences sector, with a market capitalization of approximately $804.2B. The 52-week trading range was $623.78 to $1,133.95. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

LLY - Latest Insights

LLY
Nov 04, 2026, 1:53 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,416.54
Real-time Price: $1,366.76 info
Change: -$49.78 (-4%) info
Market Cap: $1.284T info
LLY
Oct 29, 2026, 3:21 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1,368.10
Real-time Price: $1,366.76 info
Change: -$1.34 (-0.10%) info
Market Cap: $1.284T info
LLY
Oct 29, 2026, 12:08 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $1,370.30
Real-time Price: $1,366.76 info
Change: -$3.54 (-0.26%) info
Market Cap: $1.284T info
LLY
Oct 29, 2026, 11:35 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1,363.50
Real-time Price: $1,366.76 info
Change: +$3.26 (+0.24%) info
Market Cap: $1.284T info
LLY
Oct 29, 2026, 7:03 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1,344.00
Real-time Price: $1,366.76 info
Change: +$22.76 (+2%) info
Market Cap: $1.284T info